Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00103883 · ClinicalTrials.gov registry record
A Novel Method to Determine HIV Incidence Among Youth
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 440
- Enrollment target
NCT00103883: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00103883 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 440 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00103883 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 440 participants
- Enrollment target
Study Summary
Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective interventions to disease progression and improve outcome. This study will develop and evaluate a saliva-based sensitive/less sensitive (S/LS) assay for differentiating persons with recent HIV-1 infection (less than 133 days) from those with established HIV-1 infection.
Primary Outcome
To develop and calibrate a saliva S/LS assay using the FDA licensed OraSure collection device in conjunction with its matched saliva EIA assay to differentiate persons with recent versus established HIV infection (Phase I)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2003-02 |
| Est. Completion | 2007-03 |
What the finished NCT00103883 record still lists
NCT00103883 is an observational study that tracks outcomes without assigning an intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00103883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00103883 about?
NCT00103883 is a clinical study titled "A Novel Method to Determine HIV Incidence Among Youth". Identifying young people with early HIV-1 infection is important for increasing linkage to care, for behavioral counseling, and for enrolling individuals into programs that can provide effective interventions to disease progression and improve outcome. This study will develop and evaluate a saliva-b...
What is the current status of trial NCT00103883?
This trial is currently completed. The enrollment target is 440 participants. The study started on 2003-02. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00103883?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia